Endogenous Inhibitors of Tyrosine Kinase Receptors - a Therapeutic Role for Soluble LRIG1 in Malignant Glioma?

被引：1
|
作者：
Tiemann, K. [1 ]
Bernard, A. [1 ]
Fack, F. [1 ]
Johansson, M. [2 ]
Hedman, H. [2 ]
Niclou, S. P. [1 ]
机构：
[1] Ctr Rech Publ Sante CRP Sante, Luxembourg, Luxembourg
[2] Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71289-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
641
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [1] A role for LRIG1 in the regulation of malignant glioma aggressiveness
    Mao, Feng
    Wang, Baofeng
    Xiao, Qungen
    Xi, Guifa
    Sun, Wei
    Zhang, Huaqiu
    Ye, Fei
    Wan, Feng
    Guo, Dongsheng
    Lei, Ting
    Chen, Xiaoping
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (03) : 1081 - 1087
  • [2] ELUCIDATING THE MECHANISM OF RECEPTOR TYROSINE KINASE INHIBITION BY SOLUBLE LRIG1 IN GLIOBLASTOMA
    Tiemann, Katja
    Hedman, Hakan
    Niclou, Simone P.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 28 - 29
  • [3] Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
    Mao, Feng
    Holmlund, Camilla
    Faraz, Mahmood
    Wang, Wanzhong
    Bergenheim, Tommy
    Kvarnbrink, Samuel
    Johansson, Mikael
    Henriksson, Roger
    Hedman, Hakan
    [J]. ONCOGENESIS, 2018, 7
  • [4] Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
    Feng Mao
    Camilla Holmlund
    Mahmood Faraz
    Wanzhong Wang
    Tommy Bergenheim
    Samuel Kvarnbrink
    Mikael Johansson
    Roger Henriksson
    Håkan Hedman
    [J]. Oncogenesis, 7
  • [5] Lrig1 is an endogenous inhibitor of ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF
    Ledda, Fernanda
    Bieraugel, Oliver
    Fard, Shahrzad Shirazi
    Vilar, Marcal
    Paratcha, Gustavo
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (01): : 39 - 49
  • [6] LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells
    Guo, Zhentao
    Chen, Qianxue
    Liu, Baohui
    Tian, Daofeng
    Zhang, Shenqi
    Li, Mingchang
    [J]. YONSEI MEDICAL JOURNAL, 2014, 55 (05) : 1196 - 1205
  • [7] Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
    Fei Ye
    Qinglei Gao
    Tongjiang Xu
    Liang Zeng
    Yibo Ou
    Feng Mao
    Heping Wang
    Yue He
    Baofeng Wang
    Zhengming Yang
    Dongsheng Guo
    Ting Lei
    [J]. Journal of Neuro-Oncology, 2009, 94 : 183 - 194
  • [8] Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
    Ye, Fei
    Gao, Qinglei
    Xu, Tongjiang
    Zeng, Liang
    Ou, Yibo
    Mao, Feng
    Wang, Heping
    He, Yue
    Wang, Baofeng
    Yang, Zhengming
    Guo, Dongsheng
    Lei, Ting
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (02) : 183 - 194
  • [9] The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma
    Mitsutoshi Nakada
    Daisuke Kita
    Takuya Watanabe
    Yutaka Hayashi
    Jun-ichiro Hamada
    [J]. Brain Tumor Pathology, 2014, 31 : 198 - 207
  • [10] The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma
    Nakada, Mitsutoshi
    Kita, Daisuke
    Watanabe, Takuya
    Hayashi, Yutaka
    Hamada, Jun-ichiro
    [J]. BRAIN TUMOR PATHOLOGY, 2014, 31 (03) : 198 - 207
12345